[Hepatotoxicity associated with tumor immune checkpoint inhibitors].
Zhonghua Gan Zang Bing Za Zhi
; 28(2): 175-178, 2020 Feb 20.
Article
em Zh
| MEDLINE
| ID: mdl-32164073
ABSTRACT
Although tumor immune checkpoint inhibitors therapy brings survival benefits to cancer patients, it also faces many challenges, such as the occurrence of immune-mediated hepatotoxicity. Therefore, an in-depth understanding of the conditions, possible mechanisms, and risk factors that cause liver injury during the treatment of tumor immune checkpoint inhibitors will facilitate better clinical management.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos
/
Doença Hepática Induzida por Substâncias e Drogas
/
Antineoplásicos Imunológicos
/
Imunoterapia
/
Fígado
/
Neoplasias
Tipo de estudo:
Etiology_studies
/
Risk_factors_studies
Limite:
Humans
Idioma:
Zh
Ano de publicação:
2020
Tipo de documento:
Article